Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  Type 1 DiabetesChildren & TeensInfectious DiseaseIssue 701

Type of Enterovirus Linked to Type 1 Diabetes

Researchers have homed in on the group B coxsackie viruses....

Advertisement

Although there has been a considerable amount of research describing the link between type 1 diabetes and enterovirus, which is comprised of more than 100 types including the virus responsible for polio, it was not until recently that researchers from two independent studies determined the specific type of enterovirus that can attack the insulin-producing cells in the pancreas and lead to type 1 diabetes.

Enteroviruses can infect anyone; however, they are more common among infants, children and teenagers because of their lack of immunity. One of the two studies that identified the specific type of enterovirus responsible for causing type 1 diabetes involved children at genetic risk from birth until age 15 or diagnosis of the disease. This study was known as the Finnish Type 1 Diabetes Prediction and Prevention (DIPP) study. The other study, known as the VirDiab study, involved children with newly diagnosed diabetes. Both studies identified that the group B coxsackie viruses were associated with the risk of developing type 1 diabetes; whereas no association with the other 35 types was observed. The group B coxsackie viruses include six enteroviruses.

Researchers said that a vaccine against the virus, similar to a polio vaccine, might be an option eventually in preventing or delaying the onset of type 1 diabetes.

Diabetes, October 2013
 
Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 01 November, 2013 and appeared in  Type 1 DiabetesChildren & TeensInfectious DiseaseIssue 701

Past five issues: Diabetes Clinical Mastery Series Issue 225 | Issue 765 | Diabetes Clinical Mastery Series Issue 224 | Issue 764 | Diabetes Clinical Mastery Series Issue 223 |

2014 Most Popular Articles:

ADA Issues New Standards of Medical Care for Diabetes
Posted January 02, 2015
Significant Weight Loss and Drop in A1c with New Combo of Lorcaserin and Phentermine
Posted January 16, 2015
Why a Low-Carb Diet Should Be the First Approach in Diabetes Treatment
Posted December 18, 2014
New Guidelines Recommend Off-Loading to Increase Likelihood of Diabetic Foot Ulcer Healing
Posted December 26, 2014
Advancement in the Artificial Pancreas
Posted December 26, 2014
FDA Approves Weight-management Drug Saxenda
Posted December 26, 2014
Type 2 Diabetes Risk Lower for Blood Type O
Posted December 26, 2014
Early Insulin Therapy Makes an Impact
Posted December 26, 2014
Increased Mortality with Combining Sulfonylurea and Insulin
Posted December 26, 2014
Another SGLT2 Shows Positive Results
Posted December 26, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Are you comfortable recommending one of the 4 new FDA-approved weight loss drugs?
CME/CE of the Week
Patti Geil, MS, RD, FADA, CDE

Category: Nutrition
Credits: .75



Search Articles On Diabetes In Control